TFG Asset Management’s Cue Biopharma CUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-93,819
Closed -$2.96M – 43
2026
Q2
$2.96M Buy
+93,819
New +$2.12M 0.47% 31

Other funds holding CUE

TFG Asset Management's CUE Position: Q3 2026 in Review

TFG Asset Management sold out of Cue Biopharma (CUE) in Q3 2026, closing a stake of 93,819 shares — an estimated $2.96M sold.

TFG Asset Management first reported a position in CUE in Q2 2026 and held it in 1 quarter. The position peaked at $2.96M in Q2 2026. 58 funds tracked by Wall St. Rank hold CUE as of Q3 2026.

  • TFG Asset Management reported no remaining Cue Biopharma position as of Q3 2026 after selling out during the quarter.
  • TFG Asset Management sold 93,819 Cue Biopharma shares in Q3 2026, an estimated $2.96M.
  • TFG Asset Management first reported a position in Cue Biopharma in Q2 2026 and held it in 1 quarter.
  • TFG Asset Management's Cue Biopharma position peaked at $2.96M in Q2 2026.
  • 58 funds tracked by Wall St. Rank held Cue Biopharma as of Q3 2026.

Based on TFG Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.